Filing Details

Accession Number:
0000921895-18-000801
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-01 19:48:39
Reporting Period:
2018-02-28
Accepted Time:
2018-03-01 19:48:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
707388 Digirad Corp DRAD Electromedical & Electrotherapeutic Apparatus (3845) 330145723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538979 G. Matthew Molchan 1048 Industrial Court
Suwanee GA 30024
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-28 10,490 $0.00 77,819 No 4 M Direct
Common Stock Disposition 2018-02-28 3,740 $2.05 74,079 No 4 F Direct
Common Stock Acquisiton 2018-02-28 25,000 $2.14 99,079 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2018-02-28 10,490 $0.00 10,490 $0.00
Common Stock Restricted Stock Unit Acquisiton 2018-02-28 53,097 $0.00 53,097 $0.00
Common Stock Restricted Stock Unit Acquisiton 2018-02-28 53,098 $0.00 53,098 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,472 No 4 M Direct
53,097 No 4 A Direct
53,098 No 4 A Direct
Footnotes
  1. Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
  2. This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date.
  3. Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.08 to $2.15, inclusive. Mr. Molchan undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
  5. On February 28, 2017, Mr. Molchan was granted 83,923 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 28, 2018, February 1, 2019, February 1, 2020 and February 1, 2021, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period.
  6. These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, subject to the reporting person continuing to provide service through each such date.
  7. Does not include Restricted Stock Units that did not vest and were cancelled.
  8. These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, with the vesting of 100% of each such tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period.